Evidence map›Paper›PMID 37608867›Full record

ArticleFrontiers in chemistry2023

Development of a microfluidic photochemical flow reactor concept by rapid prototyping.

Robin Dinter, Suzanne Willems, Thilo Nissalk, Oguz Hastürk, Andreas Brunschweiger, Norbert Kockmann

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robin DinterLaboratory of Equipment Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, Germany.
Suzanne WillemsMedicinal Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Thilo NissalkLaboratory of Equipment Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, Germany.
Oguz HastürkMedicinal Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Andreas BrunschweigerMedicinal Chemistry, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Norbert KockmannLaboratory of Equipment Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transfer from batch to flow chemistry is often based on commercial microfluidic equipment, such as costly complete reactor systems, which cannot be easily tailored to specific requirements of technologies such as DNA-encoded library technology (DELT), in particular for increasingly important photochemical reactions. Customized photoreactor concepts using rapid prototyping technology offer a modular, flexible, and affordable design that allows for adaptation to various applications. In order to validate the prototype reactors, a photochemical pinacol coupling reaction at 368 nm was conducted to demonstrate the transfer from batch to flow chemistry. The conversion rates were optimized by adapting the design parameters of the microfluidic flow photoreactor module. Subsequently, the photoreactor module has been extended to an application with DNA-tagged substrates by switching to LEDs with a wavelength of 454 nm. The successful recovery of DNA confirmed the feasibility of the modular-designed flow photo reactor. This collaborative approach holds enormous potential to drive the development of DELT and flow equipment design.

Indexed as

batch to flowDNA-encoded chemistry (DEL)flow photoreactor conceptphotochemistryphotoredox reactionrapid prototyping

Identifiers

PMID37608867
PMCPMC10441772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.